BRCA1 and breast cancer: Although the detection rate in this study is extremely high this bias in testing should mean a cautious approach to assessing the likelihood of a BRCA1 pathogenic variant in those with a sporadic metaplastic breast cancer aged >60 years as the detection rates are likely to be very much lower.